Member Info for JSB1989

More for me at 38p

Decided to buy in today after seeing the drop each day for the last week and then the 1 million trade coming in.

Technick - Thank you, that's very helpful in my research. Looks great for a big run in the coming weeks.

Thanks for confirming this. Also would appreciate some help with this. What makes Genedrive better than the other PCR tests on the market? Is it that the test isn't temperature sensitive?

Has the market missed that Genedrive are developing a POC test or was this out before?

I wonder if Austin will be priming something up for a takeover. The only issue is Hurricane brings about £200 million of debt with it. I know that Austin was reluctant to acquire too much debt.

Why is this trading at £80 million? I’ve gone through the accounts and apart from the 400 million Eurobond due in 2021 it looks very good. I’m watching very carefully from the sidelines, the closer it moves to that 32p double bottom the more tempted I am to buy!

So Optigene using PrimerDesign tests on their machine to get quicker results?

Funny guy. Terrible CEO who has increased the value of his company almost 50x in 12 months. AHAHA!

This surely can’t stay at 2p for long after the confirmation it will be getting $45 a barrel!

Bought in this morning. Looks primed for a rerate after the results

RG is down under 6% so it’s more like 62% in sticky hands.

No evidence of any other sellers but RG

Ghia - always best to research and ask the tough questions before buying a share. It’s your money after all. Anyone thinking you are deramping by asking a legitimate question is firmly stuck in an echo chamber. Research the StemPrintER too which TILS could monetise in 2021 if it doesn’t get bought out

Bid rising on very little buying. Big order getting filled?

The seller won’t have any knowledge about ongoing trials at all.

In my view it’s £10+. That’s £1.5 billion as a minimum. The best breast cancer diagnostic sold for $2.8 billion last year and StemPrint has shown to be superior in independent trials. Then you have Forulumab which could be superior to Humira (the biggest selling drug on the planet)

For the whole company?

For the whole company?

It was a sell